New drugs for type 2 diabetes mellitus: The challenge of the health care sustainability combined with a better patient care access

Author:

Ferrara Francesco1ORCID,Zovi Andrea2ORCID,Langella Roberto3,Cavallaro Fabiola4,Nava Eduardo5,Trama Ugo6,Vitiello Antonio7ORCID

Affiliation:

1. Pharmaceutical Department, Asl Napoli 3 Sud, Naples, Italy

2. Hospital Pharmacist, School of Pharmacy, University of Camerino, Camerino, Italy

3. Italian Society of Hospital Pharmacy (SIFO), SIFO Secretariat of the Lombardy Region, Milan, Italy

4. Pharmaceutical Department, University of Naples Federico II, Naples, Italy

5. Pharmaceutical Coordination Area, Naples, Italy

6. Health Protection and Coordination of the Campania Regional Health System, Naples, Italy

7. Pharmaceutical Department, Clinical Pharmacologist, Perugia, Italy

Publisher

Informa UK Limited

Subject

Health Policy,Leadership and Management

Reference31 articles.

1. Italian Society of Diabetology (SID). Italian standards for the care of diabetes mellitus 2023. [cited 2023 Feb]. Available from: https://www.siditalia.it/informazione-home.

2. Guideline of the Italian Society of Diabetology (SID) and the Association of Medical Diabetologists (AMD). The treatment of type 2 diabetes mellitus 2023. [cited 2023 Feb]. Available from: https://snlg.iss.it/?cat=6.

3. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes

4. Pharmacotherapy of type 2 diabetes: An update and future directions

5. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Analysis of biosimilars consumption in an Italian Local Health Authority;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-17

2. Atrial fibrillation therapy with new oral anticoagulants: a real world evidence study;International Journal of Healthcare Management;2023-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3